Target intelligence / Profile preview

MT-ND2 pseudogene 7 (MTND2P7)

Target
MTND2P7
Molecular classification
Pseudogene, Other
01

Overview

MT-ND2 pseudogene 7 (MTND2P7) is a non-protein-coding pseudogene classified by the HUGO Gene Nomenclature Committee as a pseudogene variant related to the mitochondrial gene MT-ND2. MT-ND2 itself is a functional mitochondrial gene that encodes a core subunit (ND2) of NADH:ubiquinone oxidoreductase (Complex I) in the mitochondrial respiratory chain, which is involved in oxidative phosphorylation and cellular respiration. However, as a pseudogene, MTND2P7 does not encode a functional protein, and there is no evidence that it has an active biological or pathological role. It is not considered a receptor, enzyme, transporter, or any other canonical drug target class. No aliases beyond formal synonyms are in use, and this locus is not associated with direct disease risk or drug targeting. Pseudogenes are DNA sequences similar to functional genes but have lost their protein-coding ability or are otherwise nonfunctional due to mutations or lack of regulatory elements. While some mitochondrial pseudogenes may be differentially expressed in tissues or in certain diseases, including Alzheimer's disease (AD), there is no compelling evidence that MTND2P7 itself is functionally implicated. Most biomedical databases and gene nomenclature resources list MTND2P7 simply as a pseudogene and do not provide further structural, functional, or clinical relevance. The functional MT-ND2 gene is distinct: it is part of Complex I; its mutations cause several mitochondrial disorders, but this does not apply to the pseudogene. There is no indication that MT-ND2 pseudogene 7 is a valid therapeutic target or plays a recognized biological role in human disease or pharmacology. Any references suggesting functional or disease relevance for MT-ND2 should be carefully cross-checked to ensure they do not pertain to the actual functional gene, MT-ND2, rather than this pseudogene.

Other names
MTND2P7mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 pseudogene 7

Beyond the preview

Go deeper on MT-ND2 pseudogene 7 (MTND2P7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND2 pseudogene 7 (MTND2P7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call